07 October 2020: Clinical Research
Overexpression of Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
Peng Chen 1BCDEF* , Ziying Zhang 12BCDEF* , Xiang Chen 1ACDEG*DOI: 10.12659/MSM.926755
Med Sci Monit 2020; 26:e926755
Figure 3 PKMYT1 is prominently overexpressed in ccRCC. (A) PKMYT1 mRNA expression in multiple neoplasms and adjacent normal samples from the TIMER database. PKMYT1 mRNA level in ccRCC and normal kidney tissues from (B) the TCGA database, (C) GSE15641, (D) GSE36895, (E) GSE40435, and (F) GSE105261. ccRCC – clear cell renal cell carcinoma; TIMER – Tumor Immune Estimation Resource.